1. Integrated extracellular microRNA profiling for ovarian cancer screening
   Akira Yokoi et al, 2018, Nature Communications CrossRef
2. Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer
   Natalie J. Hannan et al, 2022, Gynecologic Oncology Reports CrossRef
3. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis
   Xinshuai Wang et al, 2019, Journal of Ovarian Research CrossRef
4. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers
   Ilaria Cavallari et al, 2021, Cancers CrossRef
5. Expression Profile of MiR-200 Family Members and Their Targets in Prostate Cancer
   null Maryam Khorasani et al, 2021, Cytology and Genetics CrossRef
6. Serum Biomarker Based Algorithms in Diagnosis of Ovarian Cancer: A Review
   Suchitra Kumari, 2018, Indian Journal of Clinical Biochemistry CrossRef
7. miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5
   Wei Guan et al, 2020, Journal of Oncology CrossRef
8. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics
   Mengyu Chen et al, 2022, Therapeutic Advances in Medical Oncology CrossRef
9. Therapeutic microRNAs in human cancer
   Gizem Ors-Kumoglu et al, 2019, Cytotechnology CrossRef
10. Overexpression of STAT4 under hypoxia promotes EMT through miR-200a/STAT4 signal pathway
    Yan Li et al, 2021, Life Sciences CrossRef
11. The role of miR-200 family in the regulation of hallmarks of cancer
    Klaudia Klicka et al, 2022, Frontiers in Oncology CrossRef
12. Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
    Fahmy T. Ali et al, 2022, PLOS ONE CrossRef
13. The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer
    Hamideh Aboutalebi et al, 2020, The International Journal of Biochemistry & Cell Biology CrossRef
14. High Expression of MicroRNA-200a/b Indicates Potential Diagnostic and Prognostic Biomarkers in Epithelial Ovarian Cancer
    Beilei Zhang et al, 2022, Disease Markers CrossRef
15. Unraveling a difficult diagnosis: the tricks for early recognition of ovarian cancer
    Pierluigi Giampaolino et al, 2019, Minerva Medica CrossRef
16. Circulating epithelial-mesenchymal transition-associated miRNAs are promising biomarkers in ovarian cancer
    Éva Márton et al, 2019, Journal of Biotechnology CrossRef
17. Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
    Yann Kieffer et al, 2020, Frontiers in Genetics CrossRef
18. Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases
    Nadezhda Mironova et al, 2019, Frontiers in Pharmacology CrossRef
19. Femtomolar determination of an ovarian cancer biomarker (miR-200a) in blood plasma using a label free electrochemical biosensor based onl-cysteine functionalized ZnS quantum dots
    Mahboobe Moazampour et al, 2021, Analytical Methods CrossRef
20. Defining fallopian tube‐derived miRNA cancer signatures
    Selam B. Dejene et al, 2019, Cancer Medicine CrossRef
21. Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers
    Gleb O. Skryabin et al, 2022, Cells CrossRef
22. circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c
    Shuang Liu et al, 2023, Annals of Medicine CrossRef
23. Graphene oxide-based qRT-PCR assay enables the sensitive and specific detection of miRNAs for the screening of ovarian cancer
    Chenyan Hu et al, 2021, Analytica Chimica Acta CrossRef